What's in Public Health England's pipeline?

Public Health England has 4 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Public Health England's portfolio?

Top competitors by shared drug class: CHU de Quebec-Universite Laval, CanSino Biologics Inc., Canadian Immunization Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), GlaxoSmithKline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/public-health-england.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Public Health England — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Public Health England pipeline: 3 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Men C conjugate vaccine	Men C conjugate vaccine	marketed
Men C conjugate	Men C conjugate	marketed
Hib conjugate vaccine	Hib conjugate vaccine	marketed	Conjugate vaccine	Haemophilus influenzae type b polysaccharide capsule	Immunology

Therapeutic area mix

Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

CHU de Quebec-Universite Laval · 1 shared drug class
CanSino Biologics Inc. · 1 shared drug class
Canadian Immunization Research Network · 1 shared drug class
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Heinrich-Heine University, Duesseldorf · 1 shared drug class
International Vaccine Institute · 1 shared drug class
Beijing Minhai Biotechnology Co., Ltd · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Public Health England:

Cite this brief

Drug Landscape (2026). Public Health England — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/public-health-england. Accessed 2026-05-17.